Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
CNÂ¥50.40
0.00%
(0.00) 1D
Sep 11, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
CNÂ¥50.20
High
CNÂ¥50.57
Low
CNÂ¥50.00
Mkt. cap
89.93B
Avg. vol.
8.23M
Volume
7.79M
P/E ratio
17.22
52-wk high
CNÂ¥59.96
52-wk low
CNÂ¥46.29
EPS
CNÂ¥2.93
Shares outstanding
1.78B
No. of employees
9K
Open
CNÂ¥50.20
High
CNÂ¥50.57
Low
CNÂ¥50.00
Mkt. cap
89.93B
Avg. vol.
8.23M
Volume
7.79M
P/E ratio
17.22
52-wk high
CNÂ¥59.96
52-wk low
CNÂ¥46.29
EPS
CNÂ¥2.93
Shares outstanding
1.78B
No. of employees
9K
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9.29K
Founded1902
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
9.40B
10.53B
11.60B
10.28B
Cost of goods sold
6.70B
7.85B
8.05B
7.28B
Cost of revenue
6.70B
7.85B
8.05B
7.28B
Research and development expenses
79.10M
115.55M
76.79M
112.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.39B
2.37B
1.28B
1.50B
Operating expense
1.33B
2.67B
1.44B
1.64B
Total operating expenses
8.03B
10.52B
9.48B
8.92B
Operating income
1.37B
12.79M
2.12B
1.36B
Other non operating income
-43.28M
135.88M
-17.44M
37.87M
EBT including unusual items
1.38B
428.17M
2.36B
1.92B
EBT excluding unusual items
1.47B
233.79M
2.35B
1.74B
Income tax expense
238.66M
27.40M
330.30M
255.01M
Effective tax rate
17.25%
6.40%
13.99%
13.27%
Other operating expenses
-18.86M
129.96M
6.54M
116.66M
Net income
1.14B
376.37M
2.04B
1.66B
Net profit margin
12.18%
3.57%
17.56%
16.18%
Earnings per share
0.61
0.18
1.10
0.87
Interest and investment income
136.98M
107.27M
253.40M
367.65M
Interest expense
-4.39M
-8.83M
-5.09M
-5.15M
Net interest expenses
132.58M
98.43M
248.31M
362.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.42B
70.91M
2.18B
1.43B
Gain or loss from assets sale
2.26M
-8.17M
-
-3.05K
AI content may include mistakes. Learn more
Google apps